E-Cadherin and EpCAM expression by NSCLC tumour cells associate with normal fibroblast activation through a pathway initiated by integrin αvβ6 and maintained through TGFβ signalling. (Q54380363)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	E-Cadherin and EpCAM expression by NSCLC tumour cells associate with normal fibroblast activation through a pathway initiated by integrin αvβ6 and maintained through TGFβ signalling.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24488011

E-Cadherin and EpCAM expression by NSCLC tumour cells associate with normal fibroblast activation through a pathway initiated by integrin αvβ6 and maintained through TGFβ signalling. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24488011

non-small-cell lung carcinoma

1 reference

based on heuristic

inferred from title

author name string

C Eberlein

1

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24488011

C Rooney

2

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24488011

S J Ross

3

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24488011

M Farren

4

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24488011

H M Weir

5

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24488011

S T Barry

6

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24488011

language of work or name

0 references

publication date

3 February 2014

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24488011

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24488011

34

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24488011

6

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24488011

704-716

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24488011

A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Cancer-associated fibroblasts derived from EGFR-TKI-resistant tumors reverse EGFR pathway inhibition by EGFR-TKIs

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor-resistant human lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Tumors as organs: complex tissues that interface with the entire organism

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Microenvironmental regulation of metastasis

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Fibroblasts in cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Arousal of cancer-associated stroma: overexpression of palladin activates fibroblasts to promote tumor invasion

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Activation of fibroblasts in cancer stroma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Mice that lack activity of alphavbeta6- and alphavbeta8-integrins reproduce the abnormalities of Tgfb1- and Tgfb3-null mice

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Tumour-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

How the Smads regulate transcription

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Intercellular variation in signaling through the TGF-β pathway and its relation to cell density and cell cycle phase

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Biological characterization of ARRY-142886 (AZD6244), a potent, highly selective mitogen-activated protein kinase kinase 1/2 inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor, ERBB2 (HER2), and ERBB3: a unique agent for simultaneous ERBB receptor blockade in cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-beta signaling.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Inhibition of integrin alpha(v)beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

alpha vbeta 6 Integrin promotes the invasion of morphoeic basal cell carcinoma through stromal modulation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Expression of the alphavbeta6 integrin promotes migration and invasion in squamous carcinoma cells.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Induction of epithelial to mesenchymal transition in PMC42-LA human breast carcinoma cells by carcinoma-associated fibroblast secreted factors

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

21 January 2018

Clinicopathological significance of stromal myofibroblasts in invasive ductal carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

31 March 2020

Modified scar grade: a prognostic indicator in small peripheral lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

31 March 2020

Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

31 March 2020

Stromal features are predictive of disease mortality in oral cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

31 March 2020

Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.600

31 March 2020

BIBW-2992, a dual receptor tyrosine kinase inhibitor for the treatment of solid tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24488011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24488011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of desmoplastic reaction and lymphocytic infiltration in the management of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24488011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stromal myofibroblasts in breast cancer: relations between their occurrence, tumor grade and expression of some tumour markers

1 reference

https://pubmed.ncbi.nlm.nih.gov/24488011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/ONC.2013.600

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24488011

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24488011

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54380363&oldid=2212447038"